The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV und Type V Hypertriglyceridaemia.

MLA

Kissebah, A. H., et al. “The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV Und Type V Hypertriglyceridaemia.” European Journal of Clinical Investigation, vol. 4, no. 3, June 1974, pp. 163–74. EBSCOhost, https://doi.org/10.1111/j.1365-2362.1974.tb02329.x.

APA

Kissebah, A. H., Adams, P. W., Harrigan, P., & Wynn, V. (1974). The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV und Type V Hypertriglyceridaemia. European Journal of Clinical Investigation, 4(3), 163–174. https://doi.org/10.1111/j.1365-2362.1974.tb02329.x

Chicago

Kissebah, A. H., P. W. Adams, P. Harrigan, and V. Wynn. 1974. “The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV Und Type V Hypertriglyceridaemia.” European Journal of Clinical Investigation 4 (3): 163–74. doi:10.1111/j.1365-2362.1974.tb02329.x.